NASDAQ:PODD - Insulet Stock Price, Price Target & More

$88.64 +0.82 (+0.93 %)
(As of 04/19/2018 07:54 AM ET)
Previous Close$87.82
Today's Range$87.57 - $89.30
52-Week Range$38.43 - $89.30
Volume210,600 shs
Average Volume495,434 shs
Market Capitalization$5.15 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.38

About Insulet (NASDAQ:PODD)

Insulet logoInsulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod Insulin Management System (Omnipod System), which consists of an easy-to-use continuous insulin delivery system; and Personal Diabetes Manager, a handheld wireless device. It also customizes the Omnipod System technology platform for the delivery of drugs over a specified interval of time, at an administered volume. The company sells and markets its Omnipod System through a combination of direct sales representatives and independent distributors. Insulet Corporation was founded in 2000 and is headquartered in Billerica, Massachusetts.

Receive PODD News and Ratings via Email

Sign-up to receive the latest news and ratings for PODD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:PODD
CUSIP45784P10
Phone978-600-7000

Debt

Debt-to-Equity Ratio3.57%
Current Ratio6.24%
Quick Ratio5.85%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$463.77 million
Price / Sales11.22
Cash FlowN/A
Price / CashN/A
Book Value$2.72 per share
Price / Book32.59

Profitability

EPS (Most Recent Fiscal Year)($0.46)
Net Income$-26,830,000.00
Net Margins-5.79%
Return on Equity-29.73%
Return on Assets-4.83%

Miscellaneous

Employees857
Outstanding Shares58,690,000

How to Become a New Pot Stock Millionaire

Insulet (NASDAQ:PODD) Frequently Asked Questions

What is Insulet's stock symbol?

Insulet trades on the NASDAQ under the ticker symbol "PODD."

How were Insulet's earnings last quarter?

Insulet Co. (NASDAQ:PODD) posted its earnings results on Wednesday, February, 21st. The medical instruments supplier reported ($0.12) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by $0.04. The medical instruments supplier had revenue of $130.50 million for the quarter, compared to the consensus estimate of $125.16 million. Insulet had a negative return on equity of 29.73% and a negative net margin of 5.79%. Insulet's revenue for the quarter was up 26.0% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.16) earnings per share. View Insulet's Earnings History.

When is Insulet's next earnings date?

Insulet is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for Insulet.

What price target have analysts set for PODD?

19 Wall Street analysts have issued twelve-month price objectives for Insulet's shares. Their forecasts range from $44.00 to $105.00. On average, they anticipate Insulet's share price to reach $75.4118 in the next twelve months. View Analyst Ratings for Insulet.

What are Wall Street analysts saying about Insulet stock?

Here are some recent quotes from research analysts about Insulet stock:
  • 1. According to Zacks Investment Research, "INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. " (3/13/2018)
  • 2. Northland Securities analysts commented, "Epizyme’s loss per share of $0.48 was less than our estimated $0.66. This resulted from higher than estimated revenue, which was $10 million compared to our estimated $0.6 million, and resulted from a milestone payment. Expenses were in line with expectations. Our outlook for 2017-22 remains basically unchanged. We are adjusting our 2017 estimates to reflect the milestone payment in this quarter." (8/4/2017)

Who are some of Insulet's key competitors?

Who are Insulet's key executives?

Insulet's management team includes the folowing people:
  • Mr. Patrick J. Sullivan, Chairman & CEO (Age 66)
  • Ms. Shacey Petrovic, Pres and Chief Operating Officer (Age 44)
  • Mr. Michael L. Levitz, CFO, Sr. VP, Treasurer & Principal Accounting Officer (Age 44)
  • Mr. Bradley A. Thomas, Exec. VP of HR & Organizational Devel. (Age 60)
  • Mr. Charles Alpuche, Exec. VP of Global Manufacturing and Operations (Age 58)

Has Insulet been receiving favorable news coverage?

News stories about PODD stock have trended very positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Insulet earned a coverage optimism score of 0.53 on Accern's scale. They also gave news headlines about the medical instruments supplier an impact score of 45.22 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

How do I buy shares of Insulet?

Shares of PODD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Insulet's stock price today?

One share of PODD stock can currently be purchased for approximately $88.64.

How big of a company is Insulet?

Insulet has a market capitalization of $5.15 billion and generates $463.77 million in revenue each year. The medical instruments supplier earns $-26,830,000.00 in net income (profit) each year or ($0.46) on an earnings per share basis. Insulet employs 857 workers across the globe.

How can I contact Insulet?

Insulet's mailing address is 600 TECHNOLOGY PARK DRIVE SUITE 200, BILLERICA MA, 01821. The medical instruments supplier can be reached via phone at 978-600-7000 or via email at [email protected]


MarketBeat Community Rating for Insulet (PODD)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  440 (Vote Outperform)
Underperform Votes:  380 (Vote Underperform)
Total Votes:  820
MarketBeat's community ratings are surveys of what our community members think about Insulet and other stocks. Vote "Outperform" if you believe PODD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PODD will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Insulet (NASDAQ:PODD) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
19 Wall Street analysts have issued ratings and price targets for Insulet in the last 12 months. Their average twelve-month price target is $75.4118, suggesting that the stock has a possible downside of 14.92%. The high price target for PODD is $105.00 and the low price target for PODD is $44.00. There are currently 6 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.682.672.712.60
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $75.4118$73.5625$62.1429$55.4615
Price Target Upside: 14.92% downside2.98% downside9.62% downside8.97% downside

Insulet (NASDAQ:PODD) Consensus Price Target History

Price Target History for Insulet (NASDAQ:PODD)

Insulet (NASDAQ:PODD) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/3/2018GuggenheimInitiated CoverageBuy$105.00LowView Rating Details
3/5/2018BMO Capital MarketsInitiated CoverageOutperform$90.00HighView Rating Details
2/23/2018Jefferies GroupReiterated RatingBuy$90.00LowView Rating Details
2/23/2018Canaccord GenuityBoost Price TargetNeutral$78.00 -> $88.00LowView Rating Details
2/22/2018CowenReiterated RatingOutperform -> Outperform$80.00 -> $90.00MediumView Rating Details
2/22/2018OppenheimerSet Price TargetHold$82.00HighView Rating Details
2/22/2018Morgan StanleyReiterated RatingEqual Weight -> Equal Weight$76.00 -> $87.00HighView Rating Details
2/22/2018StephensReiterated RatingEqual Weight -> Equal Weight$60.00 -> $81.00HighView Rating Details
2/22/2018BarclaysReiterated RatingOverweight -> Overweight$85.00 -> $90.00HighView Rating Details
1/8/2018Raymond JamesUpgradeMarket Perform -> Outperform$80.00HighView Rating Details
1/8/2018UBSUpgradeMarket Perform -> OutperformHighView Rating Details
11/3/2017Robert W. BairdBoost Price TargetOutperform$65.00 -> $72.00N/AView Rating Details
10/12/2017Leerink SwannReiterated RatingOutperform$65.00 -> $74.00N/AView Rating Details
10/10/2017WedbushReiterated RatingBuy$60.00 -> $65.00N/AView Rating Details
8/4/2017Northland SecuritiesReiterated RatingBuyLowView Rating Details
7/17/2017BTIG ResearchDowngradeBuy -> NeutralMediumView Rating Details
5/25/2017William BlairReiterated RatingOutperform -> OutperformLowView Rating Details
5/22/2017Piper JaffrayReiterated RatingOverweight -> Overweight$47.00LowView Rating Details
5/14/2017B. RileyReiterated RatingNeutral$44.00LowView Rating Details
2/27/2017Feltl & Co.DowngradeBuy -> HoldN/AView Rating Details
11/17/2016JPMorgan ChaseReiterated RatingHold$38.00N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingNeutralN/AView Rating Details
(Data available from 4/19/2016 forward)

Earnings

Insulet (NASDAQ:PODD) Earnings History and Estimates Chart

Earnings by Quarter for Insulet (NASDAQ:PODD)

Insulet (NASDAQ:PODD) Earnings Estimates

2018 EPS Consensus Estimate: ($0.23)
2019 EPS Consensus Estimate: $0.30
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185($0.22)($0.04)($0.14)
Q2 20185($0.18)$0.00($0.10)
Q3 20186($0.10)$0.08$0.03
Q4 20186($0.09)$0.08($0.01)
Q1 20192($0.04)$0.07$0.02
Q2 20192$0.05$0.11$0.08
Q3 20192$0.05$0.19$0.12
Q4 20192$0.08$0.09$0.09

Insulet (NASDAQ PODD) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2018($0.19)N/AView Earnings Details
2/21/2018Q4 2017($0.08)($0.12)$125.16 million$130.50 millionViewListenView Earnings Details
11/2/2017Q3 2017($0.10)($0.04)$114.02 million$121.80 millionViewN/AView Earnings Details
8/3/2017Q2 2017($0.13)($0.13)$106.23 million$110.00 millionViewListenView Earnings Details
5/8/2017Q1 2017($0.16)($0.17)$97.73 million$101.70 millionViewListenView Earnings Details
2/27/2017Q416($0.05)($0.16)$100.61 million$103.58 millionViewListenView Earnings Details
11/3/2016Q316($0.09)($0.05)$89.75 million$94.90 millionViewN/AView Earnings Details
8/3/2016Q216($0.17)($0.08)$81.10 million$87.30 millionViewN/AView Earnings Details
4/28/2016Q116($0.19)($0.19)$79.06 million$81.21 millionViewListenView Earnings Details
2/25/2016Q415($0.26)($0.48)$91.89 million$100.10 millionViewListenView Earnings Details
11/5/2015Q315($0.26)($0.33)$83.56 million$87.30 millionViewListenView Earnings Details
8/12/2015Q215($0.13)($0.27)$70.32 million$75.60 millionViewListenView Earnings Details
4/30/2015Q115($0.10)($0.21)$68.20 million$61.20 millionViewN/AView Earnings Details
2/26/2015Q414($0.04)($0.10)$73.52 million$72.60 millionViewN/AView Earnings Details
8/7/2014Q214($0.08)($0.06)$72.94 million$72.00 millionViewN/AView Earnings Details
5/7/2014Q114($0.06)($0.11)$68.47 million$69.20 millionViewN/AView Earnings Details
2/27/2014Q413($0.09)($0.04)$67.94 million$68.53 millionViewN/AView Earnings Details
11/7/2013Q313($0.16)($0.39)$62.01 million$61.10 millionViewN/AView Earnings Details
8/7/2013Q2 2013($0.19)($0.20)$60.47 million$60.09 millionViewN/AView Earnings Details
5/6/2013Q1 2013($0.21)($0.20)$57.26 million$57.40 millionViewN/AView Earnings Details
2/27/2013Q4 2012($0.21)($0.21)$59.12 million$57.80 millionViewN/AView Earnings Details
11/8/2012Q312($0.22)($0.26)$54.93 million$54.80 millionViewN/AView Earnings Details
8/8/2012($0.25)($0.30)ViewN/AView Earnings Details
5/9/2012($0.28)($0.31)ViewN/AView Earnings Details
2/9/2012($0.26)($0.30)ViewN/AView Earnings Details
11/3/2011($0.25)($0.29)ViewN/AView Earnings Details
8/2/2011($0.21)($0.42)ViewN/AView Earnings Details
5/9/2011($0.22)($0.22)ViewN/AView Earnings Details
2/15/2011($0.26)($0.50)ViewN/AView Earnings Details
11/9/2010Q3 2010($0.30)($0.30)ViewN/AView Earnings Details
7/29/2010Q2 2010($0.35)($0.36)ViewN/AView Earnings Details
5/6/2010Q1 2010($0.38)($0.37)ViewN/AView Earnings Details
2/9/2010Q4 2009($0.50)($0.43)ViewN/AView Earnings Details
10/26/2009Q3 2009($0.70)($0.88)ViewN/AView Earnings Details
8/4/2009Q2 2009($0.67)($0.73)ViewN/AView Earnings Details
5/7/2009Q1 2009($0.65)($0.71)ViewN/AView Earnings Details
3/5/2009Q4 2008($0.63)($0.72)ViewN/AView Earnings Details
11/6/2008Q3 2008($0.74)($0.75)ViewN/AView Earnings Details
8/12/2008Q2 2008($0.71)($0.87)ViewN/AView Earnings Details
5/13/2008Q1 2008($0.52)($0.73)ViewN/AView Earnings Details
3/17/2008Q4 2007($0.50)($0.59)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Insulet (NASDAQ:PODD) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insulet (NASDAQ PODD) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.60%
Insider Trading History for Insulet (NASDAQ:PODD)
Institutional Ownership by Quarter for Insulet (NASDAQ:PODD)

Insulet (NASDAQ PODD) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/16/2018Bradley A. ThomasEVPSell3,500$85.00$297,500.00View SEC Filing  
3/15/2018Charles AlpucheCOOSell7,090$84.65$600,168.50View SEC Filing  
3/14/2018Bradley A. ThomasEVPSell7,250$83.81$607,622.50View SEC Filing  
3/14/2018John A. FallonDirectorSell9,000$84.10$756,900.00View SEC Filing  
3/6/2018David A. LemoineDirectorSell641$76.81$49,235.21View SEC Filing  
3/6/2018Shacey PetrovicCOOSell1,319$76.81$101,312.39View SEC Filing  
11/13/2017James C. MullenDirectorBuy2,500$67.45$168,625.00View SEC Filing  
9/6/2017Charles AlpucheEVPBuy2,500$58.08$145,200.00View SEC Filing  
5/16/2017Michael P. SpearsSVPBuy2,500$40.59$101,475.00View SEC Filing  
5/11/2017Bradley A. ThomasEVPBuy3,000$38.69$116,070.00View SEC Filing  
5/11/2017Jessica HopfieldDirectorBuy2,580$38.68$99,794.40View SEC Filing  
5/1/2017David A. LemoineDirectorSell1,524$43.40$66,141.60View SEC Filing  
3/13/2017Regina O. SommerDirectorSell40,000$45.00$1,800,000.00View SEC Filing  
3/6/2017David A. LemoineDirectorSell1,282$45.15$57,882.30View SEC Filing  
3/2/2017Joseph S. ZakrzewskiDirectorSell40,000$46.86$1,874,400.00View SEC Filing  
12/9/2016Charles AlpucheSVPBuy6,600$37.70$248,820.00View SEC Filing  
12/2/2016Patrick J. SullivanCEOBuy40,000$33.89$1,355,600.00View SEC Filing  
12/1/2016Bradley A. ThomasEVPBuy3,100$32.45$100,595.00View SEC Filing  
5/25/2016Regina O SommerDirectorSell8,019$30.42$243,937.9820,330View SEC Filing  
5/18/2016Patrick J SullivanCEOBuy45,000$27.00$1,215,000.00202,795View SEC Filing  
5/13/2016Bradley A ThomasEVPBuy2,975$26.63$79,224.2551,315View SEC Filing  
5/5/2016Bradley A ThomasEVPBuy1,656$30.13$49,895.2848,340View SEC Filing  
3/10/2016Daniel J LevangieInsiderSell12,299$30.89$379,916.1125,358View SEC Filing  
3/7/2016Daniel J LevangieInsiderSell7,663$31.15$238,702.459,813View SEC Filing  
3/2/2016Jessica HopfieldDirectorBuy3,230$30.91$99,839.308,838View SEC Filing  
6/5/2015Patrick J SullivanCEOBuy10,000$29.39$293,900.00View SEC Filing  
5/28/2015Patrick J SullivanCEOBuy20,000$27.91$558,200.00View SEC Filing  
5/15/2015Timothy J ScannellDirectorBuy3,500$27.05$94,675.00View SEC Filing  
5/5/2015Bradley A ThomasEVPBuy1,000$27.26$27,260.00View SEC Filing  
5/5/2015Patrick RyanCOOBuy3,669$26.99$99,026.31View SEC Filing  
4/2/2015R Anthony DiehlGeneral CounselSell3,372$30.96$104,397.12View SEC Filing  
3/9/2015Patrick J SullivanCEOBuy10,000$31.93$319,300.00View SEC Filing  
3/2/2015Charles T LiamosDirectorSell4,000$32.00$128,000.00View SEC Filing  
2/12/2015Charles T LiamosDirectorSell4,000$32.00$128,000.00View SEC Filing  
1/2/2015Charles T LiamosDirectorSell4,000$46.08$184,320.00View SEC Filing  
11/3/2014Charles T LiamosDirectorSell4,000$42.95$171,800.00View SEC Filing  
10/1/2014Charles T LiamosDirectorSell4,000$36.58$146,320.00View SEC Filing  
10/1/2014R Anthony DiehlGeneral CounselSell1,250$36.59$45,737.50View SEC Filing  
9/10/2014Charles T LiamosDirectorSell4,000$35.17$140,680.00View SEC Filing  
9/2/2014Duane DesistoCEOSell20,000$36.30$726,000.00View SEC Filing  
8/1/2014Duane DesistoCEOSell20,000$34.23$684,600.00View SEC Filing  
7/1/2014Duane DesistoCEOSell20,000$40.52$810,400.00View SEC Filing  
7/1/2014R Anthony DiehlGeneral CounselSell1,250$39.65$49,562.50View SEC Filing  
6/11/2014R Anthony DiehlGeneral CounselSell17,871$37.09$662,835.39View SEC Filing  
6/9/2014Peter DevlinInsiderSell12,314$37.10$456,849.40View SEC Filing  
4/8/2014Peter DevlinInsiderSell30,000$41.25$1,237,500.0079,668View SEC Filing  
4/3/2014R Anthony DiehlGeneral CounselSell4,617$48.67$224,709.3953,246View SEC Filing  
3/6/2014R Anthony DiehlGeneral CounselSell12,458$49.28$613,930.2458,246View SEC Filing  
3/6/2014Tracey Haas WielinskiVPSell8,275$49.21$407,212.7524,000View SEC Filing  
2/3/2014Charles LiamosDirectorSell11,037$42.93$473,818.4177,316View SEC Filing  
2/3/2014Duane DesistoCEOSell20,000$42.95$859,000.00184,293View SEC Filing  
2/3/2014Peter DevlinInsiderSell30,000$42.82$1,284,600.0063,081View SEC Filing  
1/3/2014Charles LiamosCOOSell86,000$36.02$3,097,720.0077,316View SEC Filing  
1/2/2014Duane DesistoCEOSell20,000$36.07$721,400.00184,293View SEC Filing  
12/3/2013Charles LiamosCOOSell63,808$36.26$2,313,678.08118,194View SEC Filing  
11/18/2013Charles LiamosCOOSell80,000$35.60$2,848,000.00118,194View SEC Filing  
9/3/2013Duane DesistoCEOSell20,000$33.38$667,600.00182,433View SEC Filing  
8/29/2013Sally CrawfordDirectorSell9,000$33.42$300,780.007,000View SEC Filing  
8/15/2013Regina SommerDirectorSell5,000$33.32$166,600.0016,500View SEC Filing  
8/1/2013Duane DesistoCEOSell20,000$31.85$637,000.00View SEC Filing  
7/1/2013Duane DesistoCEOSell20,000$31.51$630,200.00View SEC Filing  
7/1/2013Peter DevlinInsiderSell30,000$31.48$944,400.00View SEC Filing  
6/14/2013Sally CrawfordDirectorSell31,000$30.47$944,570.00View SEC Filing  
6/10/2013R Anthony DiehlGeneral CounselSell38,455$30.50$1,172,877.50View SEC Filing  
6/3/2013Duane DesistoCEOSell20,000$29.76$595,200.00View SEC Filing  
12/3/2012Brian K RobertsCFOSell10,000$21.92$219,200.00View SEC Filing  
11/1/2012Brian K RobertsCFOSell10,000$21.49$214,900.00View SEC Filing  
9/4/2012Brian K RobertsCFOSell10,000$20.78$207,800.00View SEC Filing  
9/4/2012Duane DesistoCEOSell20,000$20.97$419,400.00View SEC Filing  
9/4/2012Ruthann DepietroVPSell1,000$20.90$20,900.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Insulet (NASDAQ PODD) News Headlines

Source:
DateHeadline
Insulet (PODD) Raised to "Buy" at Zacks Investment ResearchInsulet (PODD) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - April 17 at 8:07 PM
Insulet (PODD) Downgraded by BidaskClub to "Buy"Insulet (PODD) Downgraded by BidaskClub to "Buy"
www.americanbankingnews.com - April 14 at 4:46 PM
Edited Transcript of PODD presentation 7-Mar-17 4:35pm GMTEdited Transcript of PODD presentation 7-Mar-17 4:35pm GMT
finance.yahoo.com - April 12 at 9:53 AM
Insulet (PODD) Given "Buy" Rating at WedbushInsulet (PODD) Given "Buy" Rating at Wedbush
www.americanbankingnews.com - April 7 at 6:04 PM
BRIEF-Insulet Corp Says CEOs 2017 Total Compensation Was $8.2 Mln Vs $6 Mln In 2016BRIEF-Insulet Corp Says CEO's 2017 Total Compensation Was $8.2 Mln Vs $6 Mln In 2016
www.reuters.com - April 6 at 4:59 PM
Insulet Co. (PODD) Expected to Announce Quarterly Sales of $121.60 MillionInsulet Co. (PODD) Expected to Announce Quarterly Sales of $121.60 Million
www.americanbankingnews.com - April 6 at 4:43 AM
Insulet Co. (PODD) Receives Average Rating of "Buy" from BrokeragesInsulet Co. (PODD) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - April 4 at 9:34 PM
 Analysts Anticipate Insulet Co. (PODD) Will Post Earnings of -$0.19 Per Share Analysts Anticipate Insulet Co. (PODD) Will Post Earnings of -$0.19 Per Share
www.americanbankingnews.com - April 4 at 3:06 AM
Insulet (PODD) Coverage Initiated at GuggenheimInsulet (PODD) Coverage Initiated at Guggenheim
www.americanbankingnews.com - April 3 at 5:16 PM
Insulet (PODD) Upgraded by ValuEngine to "Buy"Insulet (PODD) Upgraded by ValuEngine to "Buy"
www.americanbankingnews.com - April 3 at 10:32 AM
Global Insulin delivery system Market Opportunities 2018: Insulet Corporation, Ypsomed Holding AG, BectonGlobal Insulin delivery system Market Opportunities 2018: Insulet Corporation, Ypsomed Holding AG, Becton
www.marketwatch.com - April 3 at 9:20 AM
Zacks Investment Research Upgrades Insulet (PODD) to HoldZacks Investment Research Upgrades Insulet (PODD) to Hold
www.americanbankingnews.com - March 25 at 10:56 PM
BidaskClub Upgrades Insulet (PODD) to Strong-BuyBidaskClub Upgrades Insulet (PODD) to Strong-Buy
www.americanbankingnews.com - March 23 at 7:56 PM
Insider Selling: Insulet Co. (PODD) EVP Sells 3,500 Shares of StockInsider Selling: Insulet Co. (PODD) EVP Sells 3,500 Shares of Stock
www.americanbankingnews.com - March 20 at 7:50 PM
Insulet (PODD) Upgraded to "Hold" at Zacks Investment ResearchInsulet (PODD) Upgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - March 18 at 11:18 AM
Insider Selling: Insulet Co. (PODD) COO Sells 7,090 Shares of StockInsider Selling: Insulet Co. (PODD) COO Sells 7,090 Shares of Stock
www.americanbankingnews.com - March 16 at 7:35 PM
Insider Selling: Insulet Co. (PODD) EVP Sells 7,250 Shares of StockInsider Selling: Insulet Co. (PODD) EVP Sells 7,250 Shares of Stock
www.americanbankingnews.com - March 16 at 7:33 PM
John A. Fallon Sells 9,000 Shares of Insulet Co. (PODD) StockJohn A. Fallon Sells 9,000 Shares of Insulet Co. (PODD) Stock
www.americanbankingnews.com - March 16 at 7:33 PM
Insulet Co. (PODD) Receives Consensus Rating of "Buy" from AnalystsInsulet Co. (PODD) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - March 10 at 9:40 PM
Insulet (PODD) Stock Rating Upgraded by BidaskClubInsulet (PODD) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - March 10 at 4:58 PM
David A. Lemoine Sells 641 Shares of Insulet Co. (PODD) StockDavid A. Lemoine Sells 641 Shares of Insulet Co. (PODD) Stock
www.americanbankingnews.com - March 8 at 9:50 PM
Insulet Co. (PODD) COO Sells $101,312.39 in StockInsulet Co. (PODD) COO Sells $101,312.39 in Stock
www.americanbankingnews.com - March 8 at 9:35 PM
Analyst: Insulet On Track For Profitability In 2018Analyst: Insulet On Track For Profitability In 2018
finance.yahoo.com - March 6 at 5:04 PM
240,327 Shares in Insulet Co. (PODD) Purchased by OppenheimerFunds Inc.240,327 Shares in Insulet Co. (PODD) Purchased by OppenheimerFunds Inc.
www.americanbankingnews.com - March 6 at 11:36 AM
Insulet Co. (PODD) Position Increased by Arrowstreet Capital Limited PartnershipInsulet Co. (PODD) Position Increased by Arrowstreet Capital Limited Partnership
www.americanbankingnews.com - March 6 at 4:38 AM
Insulet (PODD) Coverage Initiated at BMO Capital MarketsInsulet (PODD) Coverage Initiated at BMO Capital Markets
www.americanbankingnews.com - March 5 at 8:24 PM
Sectoral Asset Management Inc Invests $6.52 Million in Insulet Co. (PODD) StockSectoral Asset Management Inc Invests $6.52 Million in Insulet Co. (PODD) Stock
www.americanbankingnews.com - March 5 at 4:07 PM
54,207 Shares in Insulet Co. (PODD) Purchased by Lombard Odier Asset Management USA Corp54,207 Shares in Insulet Co. (PODD) Purchased by Lombard Odier Asset Management USA Corp
www.americanbankingnews.com - March 3 at 4:42 PM
Insulet Co. (PODD) Stake Lowered by Next Century Growth Investors LLCInsulet Co. (PODD) Stake Lowered by Next Century Growth Investors LLC
www.americanbankingnews.com - March 3 at 3:53 PM
Zacks: Analysts Expect Insulet Co. (PODD) Will Post Quarterly Sales of $121.60 MillionZacks: Analysts Expect Insulet Co. (PODD) Will Post Quarterly Sales of $121.60 Million
www.americanbankingnews.com - March 2 at 1:50 AM
-$0.19 EPS Expected for Insulet Co. (PODD) This Quarter-$0.19 EPS Expected for Insulet Co. (PODD) This Quarter
www.americanbankingnews.com - February 28 at 11:11 PM
Teacher Retirement System of Texas Has $1.37 Million Holdings in Insulet Co. (PODD)Teacher Retirement System of Texas Has $1.37 Million Holdings in Insulet Co. (PODD)
www.americanbankingnews.com - February 28 at 5:07 PM
Insulet Corporation to Present at Upcoming Investor ConferencesInsulet Corporation to Present at Upcoming Investor Conferences
finance.yahoo.com - February 28 at 9:02 AM
Insulet Co. (PODD) Holdings Reduced by Champlain Investment Partners LLCInsulet Co. (PODD) Holdings Reduced by Champlain Investment Partners LLC
www.americanbankingnews.com - February 27 at 5:38 AM
Q3 2018 Earnings Estimate for Insulet Co. Issued By Northcoast Research (PODD)Q3 2018 Earnings Estimate for Insulet Co. Issued By Northcoast Research (PODD)
www.americanbankingnews.com - February 26 at 4:48 AM
Oppenheimer Weighs in on Insulet Co.s Q3 2018 Earnings (PODD)Oppenheimer Weighs in on Insulet Co.'s Q3 2018 Earnings (PODD)
www.americanbankingnews.com - February 26 at 4:38 AM
Q1 2018 EPS Estimates for Insulet Co. Lowered by Analyst (PODD)Q1 2018 EPS Estimates for Insulet Co. Lowered by Analyst (PODD)
www.americanbankingnews.com - February 26 at 2:06 AM
William Blair Brokers Reduce Earnings Estimates for Insulet Co. (PODD)William Blair Brokers Reduce Earnings Estimates for Insulet Co. (PODD)
www.americanbankingnews.com - February 26 at 2:06 AM
Research Analysts Set Expectations for Insulet Co.s Q1 2018 Earnings (PODD)Research Analysts Set Expectations for Insulet Co.'s Q1 2018 Earnings (PODD)
www.americanbankingnews.com - February 26 at 2:06 AM
Swiss National Bank Has $6.82 Million Position in Insulet Co. (PODD)Swiss National Bank Has $6.82 Million Position in Insulet Co. (PODD)
www.americanbankingnews.com - February 25 at 6:38 AM
Insulets (PODD) "Buy" Rating Reiterated at Jefferies GroupInsulet's (PODD) "Buy" Rating Reiterated at Jefferies Group
www.americanbankingnews.com - February 24 at 3:48 PM
Insulet (PODD) PT Raised to $88.00 at Canaccord GenuityInsulet (PODD) PT Raised to $88.00 at Canaccord Genuity
www.americanbankingnews.com - February 23 at 9:44 PM
8 Stocks Getting Multiple Analyst Upgrades and Downgrades After Earnings and News8 Stocks Getting Multiple Analyst Upgrades and Downgrades After Earnings and News
www.msn.com - February 23 at 5:14 PM
Equities Analysts Offer Predictions for Insulet Co.s Q4 2019 Earnings (PODD)Equities Analysts Offer Predictions for Insulet Co.'s Q4 2019 Earnings (PODD)
www.americanbankingnews.com - February 23 at 4:34 PM
Insulet Co. (PODD) Expected to Post Q1 2019 Earnings of ($0.04) Per ShareInsulet Co. (PODD) Expected to Post Q1 2019 Earnings of ($0.04) Per Share
www.americanbankingnews.com - February 23 at 2:36 PM
Research Analysts Set Expectations for Insulet Co.s Q3 2018 Earnings (PODD)Research Analysts Set Expectations for Insulet Co.'s Q3 2018 Earnings (PODD)
www.americanbankingnews.com - February 23 at 11:54 AM
Insulet (PODD) Cut to "Sell" at Zacks Investment ResearchInsulet (PODD) Cut to "Sell" at Zacks Investment Research
www.americanbankingnews.com - February 23 at 10:06 AM
Insulet (PODD) PT Raised to $90.00 at BarclaysInsulet (PODD) PT Raised to $90.00 at Barclays
www.americanbankingnews.com - February 23 at 12:46 AM
Insulet (PODD) Given New $81.00 Price Target at StephensInsulet (PODD) Given New $81.00 Price Target at Stephens
www.americanbankingnews.com - February 22 at 6:52 PM
Insulet (PODD) Price Target Increased to $87.00 by Analysts at Morgan StanleyInsulet (PODD) Price Target Increased to $87.00 by Analysts at Morgan Stanley
www.americanbankingnews.com - February 22 at 6:52 PM

SEC Filings

Insulet (NASDAQ:PODD) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Insulet (NASDAQ:PODD) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Insulet (NASDAQ PODD) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.